Literature DB >> 6697103

"Beehive on the bladder": an indication of colovesical disease.

A V Kaisary, R W Grant.   

Abstract

The "Beehive" sign in a cystogram indicates a primary colonic disease that involves the bladder and results in lower urinary tract symptoms.

Entities:  

Mesh：

Year:  1984        PMID： 6697103     DOI： 10.1111/j.1464-410x.1984.tb07159.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


  11 in total

1.  [Intestinal neobladder fistula after radical cystectomy and orthotopic ileal neobladder].

Authors:  R Epplen; D Pfister; A Heidenreich
Journal:  Urologe A       Date:  2011-11       Impact factor: 0.639

2.  The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets.

Authors:  Zhongyi Hu; Jiao Yuan; Meixiao Long; Junjie Jiang; Youyou Zhang; Tianli Zhang; Mu Xu; Yi Fan; Janos L Tanyi; Kathleen T Montone; Omid Tavana; Ho Man Chan; Xiaowen Hu; Robert H Vonderheide; Lin Zhang
Journal:  Nat Cancer       Date:  2021-12-13

3.  Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma.

Authors:  Hu Zhao; Yuan Chen; You-Ping Liao; Hai-Mei Chen; Qiu-Hong Yang; Yin Xiao; Jing Luo; Zhen-Zhen Chen; Lai Yi; Guo-Yu Hu
Journal:  Clin Exp Med       Date:  2022-03-03       Impact factor: 3.984

4.  A Method for Coexpression Analysis.

Authors:  Boxi Zhang; Erik Norberg
Journal:  Methods Mol Biol       Date:  2022

5.  Using DNA sequencing data to quantify T cell fraction and therapy response.

Authors:  Robert Bentham; Kevin Litchfield; Thomas B K Watkins; Emilia L Lim; Rachel Rosenthal; Carlos Martínez-Ruiz; Crispin T Hiley; Maise Al Bakir; Roberto Salgado; David A Moore; Mariam Jamal-Hanjani; Charles Swanton; Nicholas McGranahan
Journal:  Nature       Date:  2021-09-08       Impact factor: 49.962

6.  Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.

Authors:  Elizabeth Heyes; Luisa Schmidt; Gabriele Manhart; Thomas Eder; Ludovica Proietti; Florian Grebien
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

7.  Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling.

Authors:  Steven M Corsello; Rohith T Nagari; Ryan D Spangler; Jordan Rossen; Mustafa Kocak; Jordan G Bryan; Ranad Humeidi; David Peck; Xiaoyun Wu; Andrew A Tang; Vickie M Wang; Samantha A Bender; Evan Lemire; Rajiv Narayan; Philip Montgomery; Uri Ben-David; Colin W Garvie; Yejia Chen; Matthew G Rees; Nicholas J Lyons; James M McFarland; Bang T Wong; Li Wang; Nancy Dumont; Patrick J O'Hearn; Eric Stefan; John G Doench; Caitlin N Harrington; Heidi Greulich; Matthew Meyerson; Francisca Vazquez; Aravind Subramanian; Jennifer A Roth; Joshua A Bittker; Jesse S Boehm; Christopher C Mader; Aviad Tsherniak; Todd R Golub
Journal:  Nat Cancer       Date:  2020-01-20

8.  FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.

Authors:  Sheng-Kai Liang; Chia-Chan Hsu; Hsiang-Lin Song; Yu-Chi Huang; Chun-Wei Kuo; Xiang Yao; Chien-Cheng Li; Hui-Chen Yang; Yu-Ling Hung; Sheng-Yang Chao; Shun-Chi Wu; Feng-Ren Tsai; Jen-Kun Chen; Wei-Neng Liao; Shih-Chin Cheng; Tsui-Chun Tsou; I-Ching Wang
Journal:  Oncogene       Date:  2021-06-21       Impact factor: 9.867

9.  Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas.

Authors:  Maya Jeitany; Aishvaryaa Prabhu; Pushkar Dakle; Elina Pathak; Vikas Madan; Deepika Kanojia; Vineeth Mukundan; Yan Yi Jiang; Yosef Landesman; Wai Leong Tam; Dennis Kappei; H Phillip Koeffler
Journal:  Cell Mol Life Sci       Date:  2020-08-26       Impact factor: 9.261

10.  Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4.

Authors:  Kathryn L Chapman; Michael D Schneider; Pelin A Golforoush; Priyanka Narasimhan; Patricia P Chaves-Guerrero; Elsa Lawrence; Gary Newton; Robert Yan; Sian E Harding; Trevor Perrior
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.